| Entorhinal Cortex Stellate Cells (Layer II) | |
|---|---|
| Lineage | Neuron > Glutamatergic > Cortical > Entorhinal Layer II |
| Markers | RELN (Reelin), CXCL14, SLC17A7, CALB2, ER81 |
| Brain Regions | Medial Entorhinal Cortex (Layer II), Lateral Entorhinal Cortex (Layer II) |
| Disease Vulnerability | Alzheimer's Disease, Frontotemporal Dementia |
Entorhinal Cortex Stellate Cells (Layer Ii) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Entorhinal [cortex[/brain-regions/cortex stellate cells are excitatory glutamatergic [neurons[/entities/neurons in layer II of the [entorhinal cortex[/brain-regions/entorhinal-cortex that serve as the principal gateway for cortical information entering the hippocampal memory system. These reelin-expressing [neurons[/entities/neurons project to the [dentate gyrus[/cell-types/dentate-granule-cells and CA3 via the perforant pathway, forming one of the most critical circuits for episodic memory formation [1][2]. In the [medial entorhinal cortex], stellate cells include grid cells — [neurons[/entities/neurons that fire in hexagonal spatial patterns to create an internal map of space — making them essential for spatial navigation and path integration [3].
Layer II stellate cells are among the earliest and most severely affected [neurons[/entities/neurons in [Alzheimer's disease[/diseases/alzheimers [1][4]. Abnormally phosphorylated tau]/proteins/tau first appears in the entorhinal [cortex[/brain-regions/cortex during Braak stages I–II, decades before clinical symptoms emerge, and the selective loss of these [neurons[/entities/neurons disrupts hippocampal input, contributing to the characteristic memory impairment of early AD [4]. Understanding why these specific cells are so vulnerable is one of the central questions in Alzheimer's Disease research.
Stellate cells are defined by their distinctive star-shaped dendritic morphology in layer II of the entorhinal [cortex[/brain-regions/cortex [3]:
The defining molecular marker of layer II stellate cells is [reelin[/proteins/reelin (RELN), a large extracellular matrix glycoprotein that distinguishes them from calbindin-positive pyramidal neurons in the same layer [1][5]:
In the medial entorhinal cortex (MEC), stellate cells include multiple functional types [3]:
In the lateral entorhinal cortex (LEC), stellate-like "fan cells" process object and context information rather than spatial signals, projecting to the dentate gyrus to encode "what" alongside the MEC's "where" information.
Stellate cells are the origin of the perforant pathway, the major excitatory input to the [hippocampus[/brain-regions/hippocampus [2]. This trisynaptic circuit is essential for memory:
Layer II stellate cells also project directly to CA3, providing an additional route for cortical information to reach the [hippocampus[/brain-regions/hippocampus. The fidelity and integrity of these projections are critical for pattern separation, spatial memory, and episodic memory encoding.
The discovery of grid cells in medial entorhinal stellate cells by Moser and Moser (2005 Nobel Prize in Physiology or Medicine, 2014) revealed that these neurons create an internal metric coordinate system for space [3]. Grid cell firing patterns are thought to arise from the unique electrophysiological properties of stellate cells, particularly their subthreshold membrane potential oscillations at theta frequency (4–12 Hz), which support path integration computations.
Stellate cells display distinctive electrophysiological properties that set them apart from pyramidal neurons:
Layer II entorhinal stellate cells are the **first neurons in the brain to develop tau[/1, 4]. This extraordinary selective vulnerability unfolds according to the Braak staging system:
**Braak stages I–II ([transentorhinal](/1, 4]. This extraordinary selective vulnerability unfolds according to the Braak staging system:
Braak stages I–II (transentorhinal): Abnormally phosphorylated tau appears in entorhinal layer II neurons, often decades before clinical symptoms. Cell loss begins in layer II stellate cells.
Braak stages III–IV (limbic): [Tau[/entities/tau-protein pathology spreads via the perforant pathway to the [hippocampus[/brain-regions/hippocampus, and layer II cell loss becomes severe.
Braak stages V–VI (neocortical): Widespread neocortical tau pathology; by this stage, up to 90% of layer II neurons may be lost [1].
Multiple converging factors render stellate cells uniquely susceptible to neurodegeneration [1][5]:
Reelin depletion: Reelin expression in layer II neurons is reduced in AD patient tissue and in animal models. Critically, naturally occurring variation in age-related cognitive decline correlates with loss of reelin expression, even independently of AD pathology [5]. Reelin normally promotes synaptic plasticity, enhances [LTP[/entities/long-term-potentiation, and reduces tau]/proteins/tau phosphorylation — its loss removes a key neuroprotective mechanism.
[BDNF[/proteins/bdnf signaling deficit: Reduced [brain-derived neurotrophic factor[/proteins/bdnf (BDNF) and acidic fibroblast growth factor (aFGF) create a hostile microenvironment for layer II neurons [5]. Factors that increase AD risk — sedentary behavior, excessive caloric intake, diabetes — simultaneously reduce BDNF levels, providing a mechanistic link between lifestyle risk factors and selective neuronal vulnerability.
Neuroinflammatory exposure: The entorhinal cortex receives dense vascular input from multiple cerebral arteries, potentially exposing layer II neurons to elevated proinflammatory cytokines including TNF-α and MCP-1 [5]. Activated [microglia[/entities/microglia, underlying theta-frequency [oscillations](/entities/microglia, underlying theta-frequency oscillations)
Disease-associated transcriptomic changes include downregulation of synaptic genes, upregulation of tau]/proteins/tau-related kinases ([GSK-3β[/entities/gsk3-beta, [CDK5[/entities/cdk5, and reduced expression of neuroprotective factors including RELN and [BDNF[/proteins/bdnf.
The study of Entorhinal Cortex Stellate Cells (Layer Ii) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.